ClaimHit for TTOs & University Tech Transfer

Licensed, unlicensed, or under-reported

Your issued patents are already out in the market. Some are licensed and reported honestly, some are licensed and quietly under-reported, and some are being practised by companies that never took a licence. ClaimHit tells you which is which — for one named licensee or across the whole portfolio — and shows the evidence behind every call.

Apply for Beta Access →See how a chart is built →
Why nobody checks
Your agreements give you audit rights. Exercising one costs more than an office will spend on a hunch, so the rights sit unused and the royalty base is whatever the licensee reports it to be.
A handful of officers against hundreds of active licences and a portfolio nobody has had time to re-examine.
Asking a licensee "is this product covered?" without technical grounding is a conversation you cannot take back.

What ClaimHit does about it

🔎

Check a licensee, by name

Target a specific company and the search scopes to their products only, scoring each against every element of the licensed claim. A quiet technical pre-check before you decide whether a formal audit is worth opening.

⚖️

The ones who never took a licence

The same search, unscoped, across the live market. University portfolios have produced some of the largest patent verdicts on record — but only in the cases where somebody checked.

📦

Screen before the renewal

Run the portfolio in batch rather than a sample. Maintenance decisions come due on a calendar; this puts evidence of who is practising each asset in front of that date.

🔗

Who cited your research

Companies whose own patents cite your asset have already engaged with the work — often years before anything shipped. That graph is searched alongside the market.

✓ Every result has to earn it

Candidates come from several models, live web and neural search, forward citations, and the authoritative registries for the field — but breadth only widens the net. Each one is still checked against real, citable evidence, and anything that cannot be evidenced is dropped rather than shown with a caveat. See every source →

Best on issued assets in fields that have since commercialised — where there is a product to find. A fresh disclosure with no market yet is the wrong job for this, and the engine will tell you so by finding nothing. Start with your largest active licence.

Apply for Beta Access →
ClaimHit is also used by (see all →)